Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Montinaro

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Immunity|March 22, 2018
Sterile Inflammation Fuels Gastric CancerAntonella Montinaro, Henning Walczak
Cell Death and Differentiation|October 4, 2022
Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveriesAntonella Montinaro, Henning Walczak
Nature Reviews. Cancer|May 25, 2017
Exploring the TRAILs less travelled: TRAIL in cancer biology and therapySilvia von Karstedt, Antonella Montinaro, Henning Walczak
EMBO Reports|December 31, 2013
Ubiquitin in the immune systemJulia Zinngrebe, Antonella Montinaro, Nieves Peltzer, et al.
Pharmacological Research|July 17, 2013
Adenosine receptors as potential targets in melanomaAntonella Montinaro, Raffaella Iannone, Aldo Pinto, et al.
Cytokine|March 1, 2011
Cl-IB-MECA enhances TNF-α release in peritoneal macrophages stimulated with LPSGiovanni Forte, Rosalinda Sorrentino, Antonella Montinaro, et al.
Plos One|October 3, 2012
Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceAntonella Montinaro, Giovanni Forte, Rosalinda Sorrentino, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma modelSilvana Morello, Rosalinda Sorrentino, Antonella Montinaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2012
Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanomaGiovanni Forte, Rosalinda Sorrentino, Antonella Montinaro, et al.
Oncogene|June 10, 2014
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cellsMark H Tuthill, Antonella Montinaro, Julia Zinngrebe, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunity|March 22, 2018
Sterile Inflammation Fuels Gastric CancerAntonella Montinaro, Henning Walczak
Cell Death and Differentiation|October 4, 2022
Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveriesAntonella Montinaro, Henning Walczak
Nature Reviews. Cancer|May 25, 2017
Exploring the TRAILs less travelled: TRAIL in cancer biology and therapySilvia von Karstedt, Antonella Montinaro, Henning Walczak
EMBO Reports|December 31, 2013
Ubiquitin in the immune systemJulia Zinngrebe, Antonella Montinaro, Nieves Peltzer, et al.
Pharmacological Research|July 17, 2013
Adenosine receptors as potential targets in melanomaAntonella Montinaro, Raffaella Iannone, Aldo Pinto, et al.
Cytokine|March 1, 2011
Cl-IB-MECA enhances TNF-α release in peritoneal macrophages stimulated with LPSGiovanni Forte, Rosalinda Sorrentino, Antonella Montinaro, et al.
Plos One|October 3, 2012
Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceAntonella Montinaro, Giovanni Forte, Rosalinda Sorrentino, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma modelSilvana Morello, Rosalinda Sorrentino, Antonella Montinaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2012
Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanomaGiovanni Forte, Rosalinda Sorrentino, Antonella Montinaro, et al.
Oncogene|June 10, 2014
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cellsMark H Tuthill, Antonella Montinaro, Julia Zinngrebe, et al.
Pageof 3